The sunrise development of antibacterial non-woven fabrics

Some leading non-woven fabric manufacturers at home and abroad have invested in antibacterial non-woven fabric production lines in order to seize opportunities in the medical and disposable sanitary products market, thereby increasing sales. The largest non-woven fabric manufacturers in Southeast Asia all adopt spunbond/spunmelt technology and focus on the hygiene market. According to forecasts, by 2020, the spunbond/spunmelt production capacity in Southeast Asia will reach 263,000 tons, of which 114,000 tons or 43% will come from Thailand, 97,000 tons or 37% in Malaysia, and 52,000 tons or 20% in Indonesia. Of which 35% is produced by Fibertex.


Spunbond/spunmelt non-woven fabric technology is taking a healthy and changing pace. While the production lines continue to meet market demand, each company must actively respond to market challenges and increasing health needs. Improving the bulkiness and softness of non-woven fabrics is very important, and antibacterial is also the top priority. These technical requirements fully reflect the vitality of non-woven fabric manufacturing technology.